Skip to main content
. 2024 May 28;10(11):e31932. doi: 10.1016/j.heliyon.2024.e31932

Fig. 2.

Fig. 2

Primary and major secondary outcomes of all patients.

(a) Primary outcome as suggested by 2021 EUGOGO guidelines; (b) major secondary outcomes.

EUGOGO, European Group on Graves' Orbitopathy.

Data are expressed as numbers (percentages).